Maurizio Silvestri

Mipharm SpA manufactures specialty pharmaceuticals and generic drugs. It operates as a third party manufacturing site for various pharmaceutical brands as well as offers integrated services such as packagaing, research, and development. The company was founded by Giuseppe G. Miglio in January 1998 and is headquartered in Milan, Italy.

Archimica SAS manufactures & distributes pharmaceutical ingredients. Archimica sites have developed unique expertise in the sterilization of bulk active pharmaceutical ingredients (APIs) using high-performance aseptic filtration technology conforming to cGMP standards (ICH Q7A and ICH Q1A compliance). The company was founded in 1987 and is headquartered in Bon-Encontre, France

Archimica SAS manufactures & distributes pharmaceutical ingredients. Archimica sites have developed unique expertise in the sterilization of bulk active pharmaceutical ingredients (APIs) using high-performance aseptic filtration technology conforming to cGMP standards (ICH Q7A and ICH Q1A compliance). The company was founded in 1987 and is headquartered in Bon-Encontre, France

Mipharm SpA manufactures specialty pharmaceuticals and generic drugs. It operates as a third party manufacturing site for various pharmaceutical brands as well as offers integrated services such as packagaing, research, and development. The company was founded by Giuseppe G. Miglio in January 1998 and is headquartered in Milan, Italy.

Mipharm SpA manufactures specialty pharmaceuticals and generic drugs. It operates as a third party manufacturing site for various pharmaceutical brands as well as offers integrated services such as packagaing, research, and development. The company was founded by Giuseppe G. Miglio in January 1998 and is headquartered in Milan, Italy.